BioCentury
ARTICLE | Top Story

Amylin submits Symlin NDA

December 7, 2000 8:00 AM UTC

AMLN submitted an NDA for Symlin, its synthetic pramlintide analog of the hormone amylin, as an adjunctive treatment for diabetic patients taking insulin. The NDA comes after completion of six Phase I...